- Home
- Publications
- Publication Search
- Publication Details
Title
FGF21 Is an Insulin-Dependent Postprandial Hormone in Adult Humans
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 102, Issue 10, Pages 3806-3813
Publisher
The Endocrine Society
Online
2017-08-05
DOI
10.1210/jc.2017-01257
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism
- (2017) ffolliott M. Fisher et al. Molecular Metabolism
- Circulating FGF21 in humans is potently induced by short term overfeeding of carbohydrates
- (2017) Anne-Marie Lundsgaard et al. Molecular Metabolism
- FGF21 Regulates Sweet and Alcohol Preference
- (2016) Saswata Talukdar et al. Cell Metabolism
- FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver
- (2016) Stephanie von Holstein-Rathlou et al. Cell Metabolism
- Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21
- (2016) Diana Ronai Dunshee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast activation protein (FAP) as a novel metabolic target
- (2016) Miguel Angel Sánchez-Garrido et al. Molecular Metabolism
- Human FGF-21 Is a Substrate of Fibroblast Activation Protein
- (2016) Andrew L. Coppage et al. PLoS One
- Circulating FGF21 proteolytic processing mediated by fibroblast activation protein
- (2015) E. Y. Zhen et al. BIOCHEMICAL JOURNAL
- FGF21 and the late adaptive response to starvation in humans
- (2015) Pouneh K. Fazeli et al. JOURNAL OF CLINICAL INVESTIGATION
- Fructose ingestion acutely stimulates circulating FGF21 levels in humans
- (2015) Jody R. Dushay et al. Molecular Metabolism
- FGF21 Acts Centrally to Induce Sympathetic Nerve Activity, Energy Expenditure, and Weight Loss
- (2014) Bryn M. Owen et al. Cell Metabolism
- Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
- (2014) K. R. Markan et al. DIABETES
- Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
- (2014) Erin E. Mulvihill et al. ENDOCRINE REVIEWS
- Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients
- (2014) J M Gallego-Escuredo et al. INTERNATIONAL JOURNAL OF OBESITY
- FGF21-based pharmacotherapy – potential utility for metabolic disorders
- (2014) Ruth E. Gimeno et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Differential Enzyme-Linked Immunosorbent Assay and Ligand-Binding Mass Spectrometry for Analysis of Biotransformation of Protein Therapeutics: Application to Various FGF21 Modalities
- (2013) Todd Hager et al. ANALYTICAL CHEMISTRY
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
- (2013) Gregory Gaich et al. Cell Metabolism
- Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs
- (2013) Fiona M. Keane et al. FEBS Open Bio
- Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity
- (2012) Oxana Ryabtsova et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Circulating Fibroblast Growth Factors as Metabolic Regulators—A Critical Appraisal
- (2012) Bo Angelin et al. Cell Metabolism
- βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism
- (2012) Xunshan Ding et al. Cell Metabolism
- FGF21 Requires βklotho to Act In Vivo
- (2012) Andrew C. Adams et al. PLoS One
- Paradoxical Regulation of Human FGF21 by Both Fasting and Feeding Signals: Is FGF21 a Nutritional Adaptation Factor?
- (2011) Takashi Uebanso et al. PLoS One
- Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
- (2010) Jody Dushay et al. GASTROENTEROLOGY
- Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models—association with liver and adipose tissue effects
- (2009) Jing Xu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
- (2009) A. O. Chavez et al. DIABETES CARE
- Response to Carbohydrate and Fat Refeeding in the Expression of Genes Involved in Nutrient Partitioning and Metabolism: Striking Effects on Fibroblast Growth Factor-21 Induction
- (2009) J. Sánchez et al. ENDOCRINOLOGY
- Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes
- (2009) Katsumi Iizuka et al. FEBS LETTERS
- Different roles of N- and C- termini in the functional activity of FGF21
- (2009) Radmila Micanovic et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men
- (2009) Charlotte Brøns et al. JOURNAL OF PHYSIOLOGY-LONDON
- Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21
- (2008) Takeshi Inagaki et al. Cell Metabolism
- Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
- (2008) X. Zhang et al. DIABETES
- βKlotho Is Required for Fibroblast Growth Factor (FGF) 21 Signaling through FGF Receptor (FGFR) 1c and FGFR3c
- (2008) Masashi Suzuki et al. MOLECULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation